SCHEMBL3498734

SCHEMBL3498734

CCOC(=O)c1oc2cc(-c3ccc(C=O)cc3)ccc2c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HSD17B10 Q99714 3/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 2/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 1/20 0.47
ALOX15 P16050 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
RAB9A P51151 5/20 0.45
NPC1 O15118 3/20 0.45
AHR P35869 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HIF1A Q16665 5/20 0.43
PARG Q86W56 2/20 0.43
USP2 O75604 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
PLK1 P53350 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3499722 0.85 HIF1A (0.55) KDM4EMAPTALDH1A1HSD17B10KMT2A
SCHEMBL3498989 0.84 KDM4E (0.53) KDM4EMAPTALDH1A1HSD17B10KMT2A
SCHEMBL17182639 0.82 HIF1A (0.54) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL20893358 0.79 L3MBTL1 (0.61) KDM4EMAPTALDH1A1HSD17B10KMT2A
SCHEMBL10739672 0.78 ALDH1A1 (0.70) KDM4EMAPTALDH1A1HSD17B10KMT2A
SCHEMBL20893409 0.77 KDM4E (0.52) KDM4EMAPTALDH1A1HSD17B10KMT2A
SCHEMBL3500416 0.77 HIF1A (0.57) KDM4EMAPTALDH1A1HSD17B10KMT2A
SCHEMBL20893367 0.77 MCL1 (0.67) KDM4EMAPTALDH1A1HSD17B10KMT2A
SCHEMBL20357978 0.77 KDM4E (0.58) KDM4EMAPTALDH1A1HSD17B10KMT2A
SCHEMBL10649408 0.77 KDM4E (0.52) KDM4EMAPTALDH1A1HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
EP-1849465-A1 AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR Takeda Pharmaceutical Company Limited (JP) 2007-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function GPR34, GPR4, GPR6 KDM4E 2059/4885MAPT 4820/4885ALDH1A1 3047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.